Patricia L. Lewis
Known title: EVP and Chief HR OfficerCIK: 0001809858
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
UnitedHealth Q3 Margins Rise, Membership Declines, Stock Volatility. UnitedHealth Group reported that Q3 operating margins improved while membership numbers slipped, a mix that could reshape the company's growth outlook. The earnings beat sparked a sharp 51% drop followed by a 40% rebound, reflecting market uncertainty. Analysts note that guidance revisions this earnings season may influence future performance.
Transaction History
| LEA | ▲ Buy | Option Exercise | 1,859 | $0 | 5/14/2026 | View on chart |
| LEA | ▲ Buy | Option Exercise | 1,337 | $0 | 5/16/2025 | View on chart |
| LEA | ▲ Buy | Option Exercise | 1,419 | $0 | 5/16/2024 | View on chart |
| LEA | ▲ Buy | Option Exercise | 1,317 | $0 | 5/18/2023 | View on chart |
| LEA | ▲ Buy | Option Exercise | 875 | $0 | 5/19/2022 | View on chart |
| UNH | ▼ Sell | Tax Withholding | 365 | $175K | 2/13/2022 | View on chart |
| UNH | ▲ Buy | Grant | 15 | $0 | 12/14/2021 | View on chart |
| UNH | ▲ Buy | Grant | 18 | $0 | 9/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
UBS and Goldman Sachs Lower Lear Price Targets
UBS and Goldman Sachs both maintained Neutral ratings on Lear but lowered their price targets to $132 and $124, respectively. This follows the stock trading near its support level, with the lower targets reflecting a more conservative outlook. The company remains in a list of attractive dividend stocks, maintaining a yield of 2.29%.
UBS and Goldman Sachs Lower Lear Price Targets. UBS and Goldman Sachs both maintained Neutral ratings on Lear but lowered their price targets to $132 and $124, respectively. This follows the stock trading near its support level, with the lower targets reflecting a more conservative outlook. The company remains in a list of attractive dividend stocks, maintaining a yield of 2.29%.